Background. Widespread use of antimicrobials has been associated with emergence of multi-drug resistant gram-negative bacteria and superinfections such as Clostridium difficile. Shortening of antimicrobial treatment duration is an approach adopted by most antimicrobial stewardship programs to reduce antimicrobial use. Although emerging evidence has advocated the use of short-course treatment in a variety of infections, the evidence in bloodstream infections remains poor. Therefore, this study aims to describe and compare the clinical outcomes of short-course (SC) and long-course (LC) antibiotic therapy.
Methods. A retrospective exploratory cohort study was conducted between April 2011 to December 2012 in adults (≥21 years-old) with uncomplicated bacteremia caused by E. coli, Klebsiella spp. and Proteus spp. The exclusion criteria were as follows: 1) immunocompromised patients; 2) presence of gram-negative bacteria found resistant to initial empiric antibiotics; 3) presence of deep-seated bacterial infections; 4) presence of concurrent infections and 5) <48 hours of antibiotic use. The study subjects were categorized into 2 groups based on the duration of antibiotic prescribed: short-course (≤10 days) and long-course (>10 days). The clinical outcomes (i.e., mortality, clinical failure, microbiological failure and bacteremia relapse), presence of C. difficile associated diarrhea and emergence of resistant isolates in subsequent infections were evaluated.
Results. A total of 337 patients with 344 independent episodes of gram-negative bacteremia were evaluated; 36 and 308 episodes were from SC and LC group respectively. LC antibiotics appeared not to have conferred clinical advantages whereas SC antibiotics did not compromise the overall treatment if source control was sufficiently achieved. Two cases of mortality and 2 cases of bacteremia relapse were observed in LC group vs 1 mortality case in SC. Emergence of resistant isolates, including Carbapenemase-resistant enterobacteriaceae, and C. difficile associated diarrhoea were present in 7 and 3 patients respectively in the LC group but none in the SC group.
Conclusion. SC antibiotics appeared not to have compromised treatment efficacy and may be considered in patients with adequate source control and evident clinical improvement.
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